Multi-faceted CRISPR/Cas technological innovation aspects in the framework of 3P medicine
Description
Since 2009, the European Association for Predictive, Preventive and Personalised Medicine (EPMA, Brussels) promotes the paradigm change from reactive approach to predictive, preventive, and personalized medicine (PPPM/3PM) to protect individuals in
